Christopher Austin, Vesalius Therapeutics CEO (Flagship)

Flag­ship's lat­est boast? A start­up that will 'rev­o­lu­tion­ize treat­men­t' for 'nine­ty per­cent of hu­man ill­ness'

Christo­pher Austin has spent the last decade build­ing a gov­ern­ment agency known in part for help­ing change drug de­vel­op­ment for rare dis­eases. Now, he’d like …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA